Pretreatment dynamic contrast-enhanced MRI biomarkers correlate with progression-free survival in primary central nervous system lymphoma Academic Article uri icon

Overview

MeSH Major

  • Infratentorial Neoplasms
  • Magnetic Resonance Imaging
  • Olivary Nucleus
  • Radiotherapy, Computer-Assisted
  • Surgical Procedures, Operative

abstract

  • Prediction of clinical outcomes in patients with primary central nervous system lymphoma (PCNSL) is important for optimization of treatment planning. Quantitative imaging biomarkers for PCNSL have not yet been established. This study evaluated the prognostic value of pretreatment dynamic contrast-enhanced MRI and diffusion-weighted imaging for progression-free survival (PFS) in patients with PCNSL.

publication date

  • January 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1007/s11060-018-2960-z

PubMed ID

  • 30073640

Additional Document Info